Sammy Elmariah MD, MPH, FACC, FAHA
Adjunct Assistant Professor, Cardiovascular Medicine
150 S Huntington Avenue | (617) 726-6120sammy.elmariah@baiminstitute.org
selmariah@mgh.harvard.edu
Sections
Cardiovascular Medicine
Biography
Dr. Elmariah graduated from the University of Pennsylvania School of Medicine and completed his internal medicine residency training at the Hospital of the University of Pennsylvania. He subsequently served as Chief Medical Resident at Lankenau Hospital. Dr. Elmariah completed his fellowship in cardiovascular medicine at the Mount Sinai Hospital in New York where he also served as Chief Fellow. While a fellow, he also completed a Masters in Public Health at the Harvard School of Public Health. Dr. Elmariah completed further fellowship training in interventional cardiology and structural heart disease at the Massachusetts General Hospital.
His clinical interest is in the management of valvular heart disease, coronary artery disease, and adult congenital heart disease. He performs transcatheter valve replacement, percutaneous coronary interventions (stents), and transcatheter closure of patent foramen ovale (PFO) and atrial septal defects (ASD).
Dr. Elmariah has a specific research interest in valvular heart disease. In addition to ongoing clinical investigation of valve calcification and the progression of aortic stenosis, Dr. Elmariah is evaluating the impact of transcatheter aortic valve replacement on myocardial metabolism and myocardial remodeling. Dr. Elmariah is an MGH Heart Center Hassenfeld Research Scholar and has been awarded the Jeremiah Stamler Distinguished Young Investigator Award and an American College of Cardiology Young Investigator Award.
Education
Medicine-Internal, MD, University of Pennsylvania School of Medicine
Clinical Research, MPH, Harvard School of Public Health
Biology, BS, Emory University
Publications
Peterson BE, Généreaux P, Shah P, Kaneko T, Elmariah S, Dobbles M, Sharma R, Vemulapali S, Garcia SA, Whisenant BK, Summers M, Bhatt DL. Mitral Regurgitation and Severe Aortic Stenosis: Clinical Characteristics, Prognostic Impact, and Response to TAVR: Insights From Egnite Data. Circ Cardiovasc Interv. 2026 Sep 11; e016578. PMID: 42723621.
Published on 9/8/2026Peterson B, Strom JB, Ryan M, Gunnarsson C, Chikermane SG, Clancy S, Elmariah S. The impact of underdiagnosis and delay in care for patients with moderate and severe aortic stenosis: A real-world database cohort study. Am Heart J Plus. 2026 Oct; 70:100884. PMID: 42761868.
Published on 8/11/2026Khalili H, Pibarot P, Elmariah S, Pilgrim T, Bavry AA, Al-Azizi K, Waggoner TE, Schwann T, Mack M, Ternacle J, Rodès-Cabau J, Abbas AE. Prognostic Impact of Measured Effective Orifice Area Index on Short-Term Mortality after Transcatheter Aortic Valve Replacement. J Am Soc Echocardiogr. 2026 Aug 11. PMID: 42580564.
Published on 8/1/2026Fanous N, Zubrzycki N, Weir L, Mohammed F, Pomeroy A, Meredith T, Roy D, Roy A, Kovacic J, Muller D, Feneley M, Elmariah S, Namasivayam M. Delay and Attrition in Severe Aortic Stenosis: A Four-Checkpoint Systematic Review of Pathway Bottlenecks and Interventions. Eur Heart J Qual Care Clin Outcomes. 2026 Aug 01. PMID: 42538860.
Published on 7/24/2026Rock CA, Chen YI, Wang R, Philip AL, Keil B, Weiner RB, Elmariah S, Mekkaoui C, Nguyen CT, Sosnovik DE. Voxel-scale diffusion tensor phenomapping of the healthy and pressure-overloaded human heart. Nat Biomed Eng. 2026 Jul 24. PMID: 42498735.
Published on 7/16/2026Coylewright M, Kolte D, Kruse G, Suri RM, Elmariah S, Strong SR, Perpetua EM. A Multicenter, Mixed Methods Study of United States Heart Teams and Health Policy: The EVOLVE Study Design and Protocol. J Soc Cardiovasc Angiogr Interv. 2026 Sep; 5(9):105512. PMID: 42774009.
Published on 6/26/2026Lindman BR, Gillam LD, Perpetua EM, Elmariah S, Otto CM, Scherrer-Crosbie M, O'Gara PT, Leon MB, Mack M, Thourani V, Gluckman TJ, Dauerman HL, Tanguturi V, Aksoy O, O'Kane S, Linn D, Jessup M, Fonarow GC, Yancy CW, Vemulapalli S. Advancing Quality in the Evaluation, Surveillance, and Management of Aortic Stenosis: A Report From the AHA Target: AS Registry. Circulation. 2026 Sep 08; 154(10):892-908. PMID: 42360276.
Published on 5/29/2026Pistorius L, Nayar NU, Tran P, Elmariah S, Dupont PE. Using Robotics to Improve Transcatheter Edge-to-Edge Repair of the Mitral Valve. IEEE Robot Autom Lett. 2026 Jul; 11(7):8463-8470. PMID: 42312103.
Published on 4/21/2026Davidson CJ, Hahn RT, Mehaffey JH, Cohen DJ, Pinney SP, Arnold SV, Stolz L, Lawlor MK, Lindenfeld J, Brener MI, Afzal AM, Smith RL, White RM, Vemulapalli S, Alu MC, Cohen E, Regan K, Sannino A, Elmariah S, Spitzer E, Blackstone EH, Lurz P, Lindman BR, Topilsky Y, Baron SJ, Chadderdon S, Khalique OK, Tang GHL, Taramasso M, Grayburn PA, Badano L, Leipsic J, Windecker S, Redfors B, Rodés-Cabau J, Ben-Yehuda O, Ailawadi G, Mack MJ, Leon MB, Badhwar V, Hausleiter J. Tricuspid Valve Academic Research Consortium-2 (TVARC-2): Trial Design and Endpoints. J Am Coll Cardiol. 2026 Apr 21; 87(15):2044-2070. PMID: 42017555.
Published on 3/26/2026Hainstock MR, Fleming G, Kim D, Aboulhosn J, Levi D, Krasuski R, Sommer R, Torres AJ, Gray R, Kereiakes D, Leventhal A, Gillespie M, Szeto W, Zajarias A, Shahanavaz S, Steinberg ZL, Jones TK, Mahadevan VS, Moore P, Elmariah S, Shirali G, Li W, Babaliaros V, Lim DS. Five-Year Outcomes for Patients With RVOT Dysfunction Treated With the SAPIEN 3 Transcatheter Heart Valve: A Pooled Analysis From the COMPASSION S3 Trial. Circ Cardiovasc Interv. 2026 May; 19(5):e016361. PMID: 41884901.